Technology News and Research

RSS

Isis Pharmaceuticals begins ISIS-DMPK Rx Phase 1 study for treatment of Myotonic Dystrophy Type 1

Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study for ISIS-DMPKRx. Isis earned a $14 million milestone payment from Biogen Idec associated with this achievement.

9 Jun 2014

Naval leaders, small business representatives converge at Navy Opportunity Forum

Top naval leaders met with representatives from some of the nation's most cutting-edge small businesses this week at the Navy Opportunity Forum in Crystal City, Va., with the goal of discovering new technologies and capabilities for America's Sailors and Marines.

9 Jun 2014

University of Indianapolis breaks ground June 19 on $28 million Health Pavilion

The University of Indianapolis will break ground June 19 on a four-story, $28 million Health Pavilion that will house UIndy's healthcare- and wellness-related academic programs as well as industry partners and clinical facilities to serve the community.

9 Jun 2014

Toshiba provides new PET/CT system for radiation and oncology imaging needs

Oncology departments can now provide their patients with a better PET/CT imaging experience using Toshiba America Medical Systems, Inc.'s all-new Celesteion (pending 510(k) clearance).

9 Jun 2014

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

BioDelivery Sciences International, Inc. received approval of the New Drug Application (NDA) for BUNAVAIL™ (buprenorphine and naloxone) buccal film (CIII) from the U.S. Food and Drug Administration (FDA).

9 Jun 2014

Rubicon signs agreements with 7 distributors to expand availability of DNA library preparation products

Rubicon Genomics, Inc., today announced that it signed agreements with seven distributors in Europe to expand the availability of its leading DNA library preparation products, including ThruPLEX®-FD Prep Kit and PicoPLEX™ DNA-seq Kit for use with Illumina® next-generation sequencing (NGS) systems and PicoPLEX™ WGA Kit for use on arrays, and to prepare for new product launches planned for the coming months.

9 Jun 2014

UST Global enters burgeoning market of patient-centered healthcare, forms alliance with Amida

UST Global, a leading provider of information technology services and solutions for Global 1000 companies, today unveiled its plans to enter the burgeoning market of patient-centered health information. It will provide a palette of services based on the Blue Button initiative. UST Global also announced a strategic alliance with Amida Technology Solutions of Silver Spring, Maryland.

9 Jun 2014

New hippomsg software designed to live "natively" on smartphones and tablets

The No. 1, free medical-texting solution is unveiling a faster platform that handles attachments during a launch party on June 19 near Fenway Park.

9 Jun 2014

Cegedim Relationship Management releases Life Sciences-specific CRM platform, Mobile Intelligence

Cegedim Relationship Management today announced the availability of the latest release of its Life Sciences-specific Customer Relationship Management (CRM) platform, Mobile Intelligence, which features a groundbreaking, complete, single platform that brings multichannel together, empowering Life Sciences teams to create better customer interactions.

9 Jun 2014

Cheetah Medical secures initial investment of $5M from growth equity firm, HighCape Partners

Cheetah Medical, Inc., a leader in non-invasive hemodynamic monitoring systems, today announced that it has secured an initial investment of $5 million from HighCape Partners, a firm co-founded by Kevin Rakin, who joined Cheetah Medical's Board of Directors in 2013.

9 Jun 2014

CFI and Group Lamerica sign new agreement

The Center for Innovation of Arlington (CFI) and Group Lamerica has established an agreement for the purpose of extending CFI business development efforts into the Latin American region.

9 Jun 2014

Co-founder of Avidity Nanomedicines to receive 2014 Prince of Asturias Award

Avidity NanoMedicines LLC, a biopharmaceutical company pioneering a breakthrough approach to the targeted delivery of nucleic acid-based medicines, announced today that its scientific co-founder, Mark E. Davis, Ph.D., will receive the 2014 Prince of Asturias Award for Technical and Scientific Research.

9 Jun 2014

TeleTracking’s hand hygiene technology redefines infection prevention standards at New Cross Hospital

New Cross Hospital, part of The Royal Wolverhampton NHS Trust, today announced a milestone of one million hand hygiene observations using TeleTracking Technologies, Inc.'s automated hand hygiene sensor as part of the 'Safe Hands' program.

9 Jun 2014

NASA astronaut to give presentation at NIH in Bethesda, Maryland

NASA astronaut Mike Hopkins, recently returned from living and working aboard the International Space Station, will give an open-media, presentation Tuesday, June 10, at the National Institutes of Health (NIH) in Bethesda, Maryland.

9 Jun 2014

Lapmaster Group Holdings acquires Peter Wolters

Lapmaster Group Holdings LLC, a leading supplier of high-precision equipment and services for lapping, polishing, grinding, and honing, announced today that it has acquired Peter Wolters GmbH, a provider of machine tools and systems for high-precision surface processing.

9 Jun 2014

Reporters reflect on health law battles

Huffington Post gathers five reporters who followed the passage and implementation of the health law to share their insights.

9 Jun 2014

Scientists design nanoparticle to target tumor cells

Scientists at UC Santa Barbara have designed a nanoparticle that has a couple of unique - and important - properties.

9 Jun 2014

Financial and industry analysts attend Allscripts' CCM conference

Today, Allscripts will host a gathering of financial and industry analysts at the Center for Connected Medicine (CCM) in Pittsburgh, Penn.

9 Jun 2014

New targets could increase effectiveness and reduce side effects linked with breast cancer treatments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found new targets for potential intervention in breast cancer. These new targets could eventually increase effectiveness and reduce the undesirable side effects associated with current treatments.

6 Jun 2014

Study: The brain controls cellular process that leads to glaucoma

Findings from a new study published in Translational Vision Science & Technology show the brain, not the eye, controls the cellular process that leads to glaucoma. The results may help develop treatments for one of the world's leading causes of irreversible blindness, as well as contribute to the development of future therapies for preserving brain function in other age-related disorders like Alzheimer's.

6 Jun 2014

Technology News and Research

Isis Pharmaceuticals begins ISIS-DMPK Rx Phase 1 study for treatment of Myotonic Dystrophy Type 1

Naval leaders, small business representatives converge at Navy Opportunity Forum

University of Indianapolis breaks ground June 19 on $28 million Health Pavilion

Toshiba provides new PET/CT system for radiation and oncology imaging needs

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

Rubicon signs agreements with 7 distributors to expand availability of DNA library preparation products

UST Global enters burgeoning market of patient-centered healthcare, forms alliance with Amida

New hippomsg software designed to live "natively" on smartphones and tablets

Cegedim Relationship Management releases Life Sciences-specific CRM platform, Mobile Intelligence

Cheetah Medical secures initial investment of $5M from growth equity firm, HighCape Partners

CFI and Group Lamerica sign new agreement

Co-founder of Avidity Nanomedicines to receive 2014 Prince of Asturias Award

TeleTracking’s hand hygiene technology redefines infection prevention standards at New Cross Hospital

NASA astronaut to give presentation at NIH in Bethesda, Maryland

Lapmaster Group Holdings acquires Peter Wolters

Reporters reflect on health law battles

Scientists design nanoparticle to target tumor cells

Financial and industry analysts attend Allscripts' CCM conference

New targets could increase effectiveness and reduce side effects linked with breast cancer treatments

Study: The brain controls cellular process that leads to glaucoma

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News